Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...